Growing community of inventors

Oslo, Norway

Oystein Fodstad

Average Co-Inventor Count = 3.95

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 21

Oystein FodstadSudhir Agrawal (3 patents)Oystein FodstadOlav Engebraaten (3 patents)Oystein FodstadGunhild Maelandsmo (3 patents)Oystein FodstadEivind Hovig (3 patents)Oystein FodstadEric Von Hofe (1 patent)Oystein FodstadGunnar Kvalheim (1 patent)Oystein FodstadGunnar Kvalbeim (1 patent)Oystein FodstadMeng Yu Wang (1 patent)Oystein FodstadOlav Engebraten (1 patent)Oystein FodstadSiri Juell (1 patent)Oystein FodstadOystein Fodstad (5 patents)Sudhir AgrawalSudhir Agrawal (152 patents)Olav EngebraatenOlav Engebraaten (3 patents)Gunhild MaelandsmoGunhild Maelandsmo (3 patents)Eivind HovigEivind Hovig (3 patents)Eric Von HofeEric Von Hofe (7 patents)Gunnar KvalheimGunnar Kvalheim (6 patents)Gunnar KvalbeimGunnar Kvalbeim (1 patent)Meng Yu WangMeng Yu Wang (1 patent)Olav EngebratenOlav Engebraten (1 patent)Siri JuellSiri Juell (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Hybridon, Inc. (3 from 98 patents)

2. The Norwegian Radium Hospital Research Foundation (2 from 4 patents)

3. Abbott Laboratories Corporation (1 from 4,177 patents)

4. Oystein Fodstad (1 from 2 patents)


5 patents:

1. RE43979 - Method for detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations

2. 7198787 - Method of killing target cells in harvested cell populations with one or more immuno-toxins

3. 5877308 - CAPL-specific oligonucleotides and methods of inhibiting metastatic

4. 5872007 - CAPL-specific oligonucleotides and methods of inhibiting metastatic

5. 5789248 - CAPL-specific oligonucleotides and method of inhibiting metastatic cancer

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/14/2025
Loading…